Document is current

Any future updates will be listed below

CDK4/6 inhibitor-SHR6390 exerts potent antitumor activity in esophageal squamous cell carcinoma by inhibiting phosphorylated Rb and inducing G1 cell cycle arrest

Crossref DOI link: https://doi.org/10.1186/s12967-017-1231-7

Published Online: 2017-06-02

Published Print: 2017-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark